These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32892614)

  • 1. How to manage patients with polyvascular atherosclerotic disease. Position paper of the International Union of Angiology.
    Poredos P; Blinc A; Novo S; Antignani PL
    Int Angiol; 2021 Feb; 40(1):29-41. PubMed ID: 32892614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
    Yakubov S
    Curr Med Res Opin; 2009 Nov; 25(11):2631-41. PubMed ID: 19769467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with Polyvascular Disease: A Very High-risk Group.
    Manolis AA; Manolis TA; Manolis AS
    Curr Vasc Pharmacol; 2022; 20(6):475-490. PubMed ID: 36098413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ankle brachial index most important to identify polyvascular disease in patients with non-ST elevation or ST-elevation myocardial infarction.
    Jönelid B; Johnston N; Berglund L; Andrén B; Kragsterman B; Christersson C
    Eur J Intern Med; 2016 May; 30():55-60. PubMed ID: 26776925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors.
    Miao B; Hernandez AV; Alberts MJ; Mangiafico N; Roman YM; Coleman CI
    J Am Heart Assoc; 2020 Jan; 9(2):e014402. PubMed ID: 31937196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic polyvascular atherosclerotic disease requires a complex management strategy--case report and review of the literature.
    Jurcut R; Florian A; Zarma L; Arsenescu I; Rosca M; Calin A; Ginghina C
    J Med Life; 2009; 2(3):254-61. PubMed ID: 20112468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of polyvascular disease in patients with carotid artery disease and peripheral artery disease.
    Vlajinac HD; Marinković JM; Maksimović MZ; Radak DJ; Arsić RB; Jorga JB
    Kardiol Pol; 2019 Oct; 77(10):926-934. PubMed ID: 31456586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral arterial occlusive disease as predictor of high atherosclerotic burden].
    Espinola-Klein C; Vosseler M; Abegunewardene N; Himmrich L; Schlosser A; Schuster CJ
    Herz; 2019 Feb; 44(1):40-44. PubMed ID: 30627741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of Atherosclerotic Plaques in Different Vascular Territories: Clinical Relevance.
    Poredos P; Poredos P; Jezovnik MK
    Curr Vasc Pharmacol; 2018 Jan; 16(2):125-129. PubMed ID: 28245772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal arterial disease: clinical implications and management.
    Paraskevas KI; Geroulakos G; Veith FJ; Mikhailidis DP
    Curr Opin Cardiol; 2020 Jul; 35(4):412-416. PubMed ID: 32371620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of arterial hypertension and type 2 diabetes mellitus with type of polyvascular atherosclerotic disease.
    Dilic M; Dzubur A; Kusljugic Z; Balic S; Pepic E
    Med Arh; 2010; 64(5):264-8. PubMed ID: 21287949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
    Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
    JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of peripheral artery disease and the role of antiplatelet therapy.
    Aronow H; Hiatt WR
    Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lifestyle and risk factor modification on occlusive peripheral arterial disease outcomes: standard healthcare vs structured programme-for a randomised controlled trial protocol.
    Elfghi M; Jordan F; Dunne D; Gibson I; Jones J; Flaherty G; Sultan S; Tawfick W
    Trials; 2021 Feb; 22(1):138. PubMed ID: 33581715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy.
    Weissler EH; Jones WS; Desormais I; Debus S; Mazzolai L; Espinola-Klein C; Nikol S; Nehler M; Sillesen H; Aboyans V; Patel MR
    Atherosclerosis; 2020 Dec; 315():10-17. PubMed ID: 33190107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
    Bhatt DL; Peterson ED; Harrington RA; Ou FS; Cannon CP; Gibson CM; Kleiman NS; Brindis RG; Peacock WF; Brener SJ; Menon V; Smith SC; Pollack CV; Gibler WB; Ohman EM; Roe MT;
    Eur Heart J; 2009 May; 30(10):1195-202. PubMed ID: 19339264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of polyvascular disease--is there any rule?
    Despotovic N; Erceg P; Brajovic M; Sekularac N; Milosevic D; Davidovic M
    Adv Gerontol; 2008; 21(3):420-3. PubMed ID: 19432176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Similarities and differences among patients with symptomatic atherosclerosis affecting several territories. The AIRVAG cohort (Integral Attention to Global VAscular Risk)].
    Guijarro C; Mesa N; Jiménez J; Puras E; Sánchez C; Fernández-Sánchez FJ; González-Anglada I; Luján S; Belinchón JC; Casas ML; López-Bescós L;
    Med Clin (Barc); 2006 Oct; 127(16):605-11. PubMed ID: 17145025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ESC guidelines 2017 on peripheral arterial diseases : Summary of the most important recommendations and innovations].
    Espinola-Klein C
    Herz; 2017 Dec; 42(8):721-727. PubMed ID: 29143147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance and prevalence of subclinical atherosclerosis in different vascular territories.
    Moreyra E; Moreyra C; Tibaldi MA; Crespo F; Arias V; Lepori AJ; Moreyra EA
    Vascular; 2020 Jun; 28(3):285-294. PubMed ID: 31964294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.